Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Gastroenterology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Prilosec (omeprazole)

Company: Astra Merck
Approval Status: Approved January 1998
Treatment Area: Heartburn

General Information

Prilosec (omeprazole) has been approved in a new dosage strength of 40 mg capsules. The drug is currently available in 10 mg and 20 mg capsules, and is an antisecretory compound for use as therapy for heartburn and other symptoms associated with gastroesophageal reflux disease (GERD).

Side Effects

Side effects of Prilosec are reported to be usually transient and mild, and include diarrhea and abdominal pain.

Mechanism of Action

Prilosec the first in a class of antisecretory compounds known as proton pump inhibitors.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.